Latest Articles
newsGP - First-of-its-kind study gives ‘baseline’ for endometriosis diagnosis - Royal Australian College of General Practitioners (RACGP)
newsGP - First-of-its-kind study gives ‘baseline’ for endometriosis diagnosis Royal Australian College of General Practitioners (RACGP)
Published: Oct. 21, 2025, 5:28 a.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace
Published: Oct. 21, 2025, 5:15 a.m.
Study reveals significant increase in diagnosis of endometriosis in women attending Australian general practice - Monash University
Study reveals significant increase in diagnosis of endometriosis in women attending Australian general practice Monash University
Published: Oct. 21, 2025, 12:02 a.m.
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women - VOI.ID
Symptoms Of Endometrosis Experienced By Barbara Palvin, A Disease Often Ignored By Women VOI.ID
Published: Oct. 20, 2025, 9:35 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal
Published: Oct. 20, 2025, 9:33 p.m.
Endometrial Ablation as a Safe Treatment for Adenomyosis-Related Abnormal Uterine Bleeding in Women with Cerebral Infarction: A Case Report - Frontiers
Endometrial Ablation as a Safe Treatment for Adenomyosis-Related Abnormal Uterine Bleeding in Women with Cerebral Infarction: A Case Report Frontiers
Published: Oct. 20, 2025, 9 p.m.
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer - Pulse 2.0
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer Pulse 2.0
Published: Oct. 20, 2025, 3:54 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in E - PharmiWeb.com
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in E PharmiWeb.com
Published: Oct. 20, 2025, 3:02 p.m.
Bella Hadid says ‘it’s hard to take a shower most days’ and is ‘excruciating pain’ due to Lyme disease condition - AOL.com
Bella Hadid says ‘it’s hard to take a shower most days’ and is ‘excruciating pain’ due to Lyme disease condition AOL.com
Published: Oct. 20, 2025, 2:55 p.m.
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider
Published: Oct. 20, 2025, 2:27 p.m.
Link copied to clipboard!